Kristel Doets
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kristel Doets has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Gorben P. Pijlman
Wageningen University
2 shared publications - Monique M. van Oers
Wageningen University & Research
2 shared publications - Carmen van de Waterbeemd1 shared publication
Henk Pouwels
MSD Animal Health, Wim de Körverstraat 35, Boxmeer 5831AN, the Netherlands
1 shared publicationIrene Slits
Laboratory of Virology, Wageningen University & Research, Droevendaalsesteeg 1, Wageningen 6708PB, the Netherlands
1 shared publication- Jelke Jan Fros
Laboratory of Virology, Wageningen University and Research, Wageningen, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 5 October 2026
- Published by Elsevier in Molecules and Cells
- Vol. 49 (12)
Presplicing factors associate with UpA-rich RNA and limit flavivirus replication
- 5 October 2026
- Published by Elsevier in Molecules and Cells
- Vol. 49 (12)
Open AccessPresplicing factors associate with UpA-rich RNA and limit flavivirus replication
- Open Access
Towards sequential conjugation-assisted laboratory evolution (SCALE) of Cas nucleases
DNA endonucleases such as the CRISPR-associated enzymes Cas9 and Cas12a constitute powerful molecular tools with a wide range of applications. To facilitate optimization of these enzymes, we investigated a fully in vivo selection system for laboratory evolution based on plasmid conjugation. In the proposed method, DNA cleavage promotes plasmid transfer to other cells, allowing cleaving variants to spread through the bacterial culture via consecutive conjugations. We have investigated whether the conjugation system of the F plasmid of E. coli is suitable for laboratory evolution of Cas nucleases. Through a series of conjugation experiments, we found (i) that the F plasmid can spread through bacterial cultures, (ii) that the FinOP conjugation inhibition system is a potential nuclease target as it can prevent transfer of non-cleaving variants (counterselection), and (iii) that a trimmed version of the F plasmid allows for consecutive conjugations. Overall, we were able to show that in many regards, conjugation can indeed be used as means of in vivo laboratory evolution. We discuss the potential of the here presented concept for a yet to be developed laboratory evolution platform.
Open AccessTowards sequential conjugation-assisted laboratory evolution (SCALE) of Cas nucleases
DNA endonucleases such as the CRISPR-associated enzymes Cas9 and Cas12a constitute powerful molecular tools with a wide range of applications. To facilitate optimization of these enzymes, we investigated a fully in vivo selection system for laboratory evolution based on plasmid conjugation. In the proposed method, DNA cleavage promotes plasmid transfer to other cells, allowing cleaving variants to spread through the bacterial culture via consecutive conjugations. We have investigated whether the conjugation system of the F plasmid of E. coli is suitable for laboratory evolution of Cas nucleases. Through a series of conjugation experiments, we found (i) that the F plasmid can spread through bacterial cultures, (ii) that the FinOP conjugation inhibition system is a potential nuclease target as it can prevent transfer of non-cleaving variants (counterselection), and (iii) that a trimmed version of the F plasmid allows for consecutive conjugations. Overall, we were able to show that in many regards, conjugation can indeed be used as means of in vivo laboratory evolution. We discuss the potential of the here presented concept for a yet to be developed laboratory evolution platform.